Alvotech Prices $152M Public Offering and Concurrent Private Placement
Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment
Negative
Importance
8
Price
$3.91
Mkt Cap
$1.323B
52W Low
$2.94
52W High
$9.94
52W Position
33% above low
Off High
61% below high
Rel. Volume
1.1× avg
Market data snapshot near publication time
ALVO sits 33% above its 52-week low of $2.94.
Summary
Alvotech has priced a $152 million public offering of ordinary shares and a concurrent private placement. This follows previous announcements of a proposed $125 million offering, indicating an increased capital raise. The offering is substantial relative to the company's market capitalization, which will result in significant dilution for existing shareholders.
At the time of this announcement, ALVO was trading at $3.91 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.3B. The 52-week trading range was $2.94 to $9.94. This news item was assessed with negative market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.
Price Chart
ALVO - Latest Insights
ALVO
Aug 31, 2026, 8:00 AM EDT
Price at Filing:
$4.96
Real-time Price:
$5.21
Change:
+$0.245 (+5%)
Market Cap:
$2.032B
ALVO
Aug 31, 2026, 4:30 AM EDT
Price at Filing:
$4.98
Real-time Price:
$5.21
Change:
+$0.225 (+5%)
Market Cap:
$2.032B
ALVO
Aug 21, 2026, 10:37 AM EDT
Price at Filing:
$4.41
Real-time Price:
$5.21
Change:
+$0.795 (+18%)
Market Cap:
$2.032B
ALVO
Aug 21, 2026, 9:00 AM EDT
Price at Filing:
$4.33
Real-time Price:
$5.21
Change:
+$0.8704 (+20%)
Market Cap:
$2.032B
ALVO
Aug 19, 2026, 4:37 PM EDT
Price at Filing:
$4.10
Real-time Price:
$5.21
Change:
+$1.11 (+27%)
Market Cap:
$2.032B